Intellectual Property and Medicine - part 1
MP3 download
110 clots per million Astrazeneca doses by Ian Woolf,
Professor Matthew Rimmer talks about intellectual property and COVID vacccines - part 1
Hosted and produced by Ian Woolf
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
New Study Finds ‘Small’ Blood Clot Risk After One AstraZeneca Vaccine Dose, Rates Are Higher Than Expected For General Population
AstraZeneca’s Clot Risks Quantified.
Rate of COVID-19 vaccine-related blood clots may be as high as 1 in 55,000: NACI
May 31, 2021